The Evolving Druggability and Developability Space: Chemically Modified New Modalities and Emerging Small Molecules.

Area of Science:

• Drug discovery and development
• Medicinal chemistry
• Pharmacology

Background:

• Lipinski's rule-of-five (Ro5) historically guided oral drug design for traditional targets.
• The post-genomic era necessitates new strategies for challenging biological targets.
• Novel molecular modalities are emerging for transformative therapeutics.

Purpose of the Study:

• To discuss the evolving landscape of druggability and developability.
• To provide an overview of novel targets and molecular modalities.
• To analyze development challenges and strategies for emerging drug classes.

Main Methods:

• Review of current literature on drug discovery trends.
• Analysis of druggability and developability aspects of novel modalities.
• Discussion of chemistry and formulation strategies for candidate progression.

Main Results:

• Identification of key challenges in developing beyond the rule-of-five (bRo5) modalities.
• Overview of strategies for modulating challenging targets with novel molecules.
• Exploration of emerging chemistry and formulation approaches.

Conclusions:

• The drug discovery paradigm is expanding to include challenging targets and diverse molecular modalities.
• Addressing developability challenges is crucial for the success of novel therapeutics.
• A comprehensive understanding of druggability and developability is essential for future drug development.